Sarah Leary
About
Pediatric Neuro-oncologist
Seattle Children's Hospital
Sarah Leary, MD, MS, is the Medical Director of the Pediatric Brain Tumor Program and the Medical Director of Clinical Research in the Cancer and Blood Disorders Center at Seattle Children’s Hospital. She is an Associate Professor of Pediatrics at the University of Washington School of Medicine and affiliated with the Fred Hutchinson Cancer Research Center. Her clinical and research focus is in the area of precision medicine and therapy development to improve survival for children with brain tumors.
Nationally, Dr. Leary has led multiple therapeutic clinical trials. She is the clinical vice-chair of the CNS committee of the Children’s Oncology Group (COG), and the Seattle Children’s site investigator for the Pacific Neuro-Oncology Consortium (PNOC) as well as the CONNECT consortium. Within the CBTN, Dr. Leary leads the clinical data working group.
"It is a privilege to work with children as part of a multidisciplinary team of clinicians and researchers who are so dedicated to providing the best care for our patients today while at the same time working to find a cure for every child in the future. My favorite days are those when I receive notes and pictures from my former patients who now are living long, healthy lives free of cancer."
Seattle Children's Hospital
research
Interests
Medulloblastoma
Medulloblastomas comprises the vast majority of pediatric embryonal tumors and by definition arise in the posterior fossa, where they constitute approximately 40% of all posterior fossa tumors. Other forms of embryonal tumors each make up 2% or less of all childhood brain tumors.The clinical feature
Ependymoma
Ependymomas arise from ependymal cells that line the ventricles and passageways in the brain and the center of the spinal cord. Ependymal cells produce cerebrospinal fluid (CSF). These tumors are classified as supratentorial or infratentorial. In children, most ependymomas are infratentorial tumors
related
